Extracts of Actaea racemosa are frequently used for the treatment of postmenopausal disorders. The mechanism of action, however, remains unclear. In the present study, potential sedative and anxiolytic effects of actein were analysed in vivo in a mouse model. Actein (6 mg/kg BW) significantly decreased the spontaneous motor activity of mice in the open field paradigm. Moreover, actein at concentrations ≥ 0.2 mg/kg BW slightly increased the time spent and the visits in the open arms in the elevated-plus-maze test and significantly increased the time spent in the brightly lit area in the light-darkchoice test. A significant decrease of ΔT caused by 6 and 20 mg/kg BW actein was observed in the stress-induced hyperthermia test. These data suggest that actein possesses in vivo sedative and anxiolytic properties that might contribute to the benefits of Actaea racemosa extracts in the treatment of postmenopausal disorders.
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